# Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

> **NCT06088121** · NA · RECRUITING · sponsor: **Advanced Technology & Communications** · enrollment: 180 (estimated)

## Conditions studied

- Alzheimer's Disease
- Dementia
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurodegenerative Diseases
- Neurocognitive Disorders
- Mental Disorder

## Interventions

- **DEVICE:** ATNC MDD-V1 (Real TMS + Real Cog)
- **DEVICE:** ATNC MDD-V1 (Sham TMS + Real Cog)
- **DEVICE:** ATNC BN-V1
- **DEVICE:** ATNC BN-V2

## Key facts

- **NCT ID:** NCT06088121
- **Lead sponsor:** Advanced Technology & Communications
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-15
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-06-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06088121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06088121, "Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06088121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*